An Open Letter to the APSA Leadership and Members

Autor: SM Walt, MW McCann, R Art, M Mattern, G Shiffman, AM Hallum, E Rhodes, WR Nylen, N Tannenwald, Alyson D. Pereira, S Kaufman, MA Orlie, RA Falk, SL Fisher, RJ Lieber, SE Lawrence, Stacey Zeigler, RM Smith, EA Cohen, H Gillman, C Howell, S Krishna, PI Weizer, BA Aquino, M Kelly, A Hearst, J Novkov, D Schlosberg, RJ Ellis, F Buntman, MM Howard, Artemus Ward, Richard K. Betts, J Bielasiak, Lyn Kathlene, PA Hall, GB Markus, S Mainwaring, KL Scheppele, S Roy, P Maclachlan, Jennifer L. Hochschild, Fred Eidlin, T DeLuca, CS Allen, TU Berger, SM Talarico, DL Scruggs, M Bernhard, D Warren, CM Henry, C Tilly, J Morone, J Kirkpatrick, D Lempert, J Grant, JS Migdal, G Ritter, R Pape, A Reed, M Smiley, C Brooke, A Rubinoff, H Reiter, D Singerman, M Aronoff, DM Barrett, David Pion-Berlin, C Wood, ZD Barany, D Baumgold, S Shulman, A Manuel, TM Keck, D Hellinger, DP Kommers, J Sowers, M Paris, JC Scott, M Blecher, TM Nichols, L Berman, JL Mercer, EI Robinson, JE Oliver, R Licklider, W Sewell, AM Tripp, DV Edwards, G Sheridan, E Hilbink, P Pettavino, PT Jackson, L Fernandes, G Munck, E Hershberg, EC Epstein, S Burgess, M Gottschalk, BS Steel, WC Wohlforth, BC Buzan, TW Luke, S Skowronek, L Zerilli, RS Gilmour, CE Zirakzadeh, EJ Willis, N Subramanian, H Chae, G Shulmam, F Lewis, R Kleff, VS Peterson, WM Lunch, P Kens, G Berk, Sperling, T Moustafa, ZA Smith, AB Strong, M Woo-Cumings, P Euben, E Gibson, A Norton, TS Schrock, JC Foster, Hattam, J Tulis, Sherrill Stroschein, T Skocpol, L Gustafson, J Mearsheimer, J Bowersox, G Kasza, SE Berman, C Swidorski, M Nincic, J Fetzer, J Lapalombara, PA Klinkner, G Mounce, Richard H. Price, BJ Callaway, I Shapiro, JB Krutky, JL Walker, KM McClure, H Krisch, SE Hanson, G Herrigel, L Jensen, D Tichenor, A Marx, D Schultz, J Dean, PR Brass, J Ehrenber, P Harris, R Vitalis, B Honig, Raymond D Duvall, D Philpott, J Carens, J Bokina, W Brown, EO Goldman, P Pierson, Alexander Wendt, E Wingrove, S Frost, D Hart, RJ Spitzer, J Nassar, T Lightcap, G DiZerega, KJ Bybee, C Schneider, KR Mayer, T Duvall, S Crowley, C Kaufmann, B Cumings, B Schneider, A Varshney, G Rose, M Blyth, SH Rudolph, T Farer, KE Ferguson, SE Bronner, C Clayton, S Benhabib, M Young, JS Kopstein, AS Jeydel, G Chowdhry, K Woodside, LH Carter, K Lieber, L Rudolph, Samer Shehata, LK Olson, L Wedeen, RM Johnstone, PD Siplon, J Goldberg-Hiller, A Seleny, J Gerring, M Keck, C Smith, D Will, B Barratt, Michael C. Desch, AC Lin, S Van Evera, SE Mendelson, Fair, L Suhay, A Klotz

Publikováno v: PS: Political Science & Politics. 33:735-737

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::40e586dde0efc41958c951a62bdd4c63
https://doi.org/10.1017/s104909650006193x

Functional Septorhinoplasty in Unilateral and Bilateral Nasal Obstruction: A Comparison of Patient-Reported Outcomes.

Autor: Randall NR; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN, USA., Barrett DM; Department of Head and Neck Surgery & Communication Sciences, Duke University Health System, Durham, NC, USA., Frank-Ito DO; Department of Head and Neck Surgery & Communication Sciences, Duke University Health System, Durham, NC, USA., Ji KSY; Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, Portland, OR, USA., Hoang T; Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, Portland, OR, USA., Wang TD; Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, Portland, OR, USA., Loyo M; Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, Portland, OR, USA.

Publikováno v: The Annals of otology, rhinology, and laryngology [Ann Otol Rhinol Laryngol] 2024 Dec 27, pp. 34894241309751. Date of Electronic Publication: 2024 Dec 27.

CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

Autor: Patel RP; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Ghilardi G; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Zhang Y; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Chiang YH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, MacKay Memorial Hospital, Taipei, Taiwan., Xie W; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Guruprasad P; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Kim KH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Chun I; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Angelos MG; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Pajarillo R; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Hong SJ; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Lee YG; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of Korea., Shestova O; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA., Shaw C; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Cohen I; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Gupta A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Vu T; viTToria Biotherapeutics, Philadelphia, PA, USA., Qian D; viTToria Biotherapeutics, Philadelphia, PA, USA., Yang S; viTToria Biotherapeutics, Philadelphia, PA, USA., Nimmagadda A; viTToria Biotherapeutics, Philadelphia, PA, USA., Snook AE; viTToria Biotherapeutics, Philadelphia, PA, USA., Siciliano N; viTToria Biotherapeutics, Philadelphia, PA, USA., Rotolo A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Inamdar A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA., Harris J; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA., Ugwuanyi O; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Wang M; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Carturan A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Paruzzo L; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Chen L; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Ballard HJ; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Blanchard T; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Xu C; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Abdel-Mohsen M; Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA, USA., Gabunia K; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Wysocka M; Department of Dermatology, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA., Linette GP; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Carreno B; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Barrett DM; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Oncology, Children's Hospital of Philadelphia, PA, USA., Teachey DT; Division of Oncology, Children's Hospital of Philadelphia, PA, USA., Posey AD; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Powell DJ Jr; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA., Sauter CT; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Pileri S; Division of Haematopathology, Istituto Europeo di Oncologia IRCCS, Italy., Pillai V; Division of Hemato-pathology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Scholler J; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Rook AH; Department of Dermatology, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA., Schuster SJ; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Barta SK; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Porazzi P; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Ruella M; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

Publikováno v: Science immunology [Sci Immunol] 2024 Jul 19; Vol. 9 (97), pp. eadn6509. Date of Electronic Publication: 2024 Jul 19.

Facial fillers: Relevant anatomy, injection techniques, and complications.

Autor: Clark NW; Duke University Department of Head and Neck Surgery and Communication Sciences Durham North Carolina USA., Pan DR; Duke University Department of Head and Neck Surgery and Communication Sciences Durham North Carolina USA., Barrett DM; Duke University Department of Head and Neck Surgery and Communication Sciences Durham North Carolina USA.

Publikováno v: World journal of otorhinolaryngology - head and neck surgery [World J Otorhinolaryngol Head Neck Surg] 2023 Aug 02; Vol. 9 (3), pp. 227-235. Date of Electronic Publication: 2023 Aug 02 (Print Publication: 2023).

Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing.

Autor: Chen GM; Graduate Group in Genomics and Computational Biology, University of Pennsylvania, Philadelphia, Pennsylvania., Chen CH; Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Perazzelli J; Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Grupp SA; Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania., Barrett DM; Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania., Tan K; Graduate Group in Genomics and Computational Biology, University of Pennsylvania, Philadelphia, Pennsylvania.; Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania.

Publikováno v: Cancer immunology research [Cancer Immunol Res] 2023 Jan 03; Vol. 11 (1), pp. 13-19.